EM was the recipient of a Diabetes Canada New Investigator Award, NSERC Discovery Grant RGPIN-2017-05996, and Diabetes Canada New Investigator NC-3-18-5425
Always follow the specific instructions on your medication label, and if youre ever unsure, check with your pharmacist
Though not common, some side effects of these medications can be severe
ADM has received research funding from the European Union, Medical Research Council (MRC), National Institute for Health and Care Research (NIHR), HSC R&D division, Jon Moulton Charitable Foundation, Anabio, Fractyl, Boehringer Ingelheim, Eli Lilly and Company, Gila, Randox, and Novo Nordisk
These degradation products may be more immunogenic than the intact peptide molecule
The broader context: why this problem exists Grey market tirzepatide is a symptom of a larger healthcare access problem